Global Metal Non Covered Biliary Stent Market Size By Type (Absorbable, Non Absorbable), By Application (Hospital, Medical Center), By Region, And Segment Forecasts, 2023 to 2032

The Global Metal Non-Covered Biliary Stent Market was valued at USD 412.3 million in 2023 and is projected to reach USD 758.6 million by 2031, growing at a CAGR of 7.9% during the forecast period from 2023 to 2031. The increasing incidence of biliary strictures due to malignancies, advancements in stent technology, and a growing preference for minimally invasive procedures are the primary factors fueling market growth. Metal non-covered biliary stents are widely used in the palliative treatment of malignant biliary obstruction due to their longer patency and lower migration rates compared to plastic stents, enhancing patient outcomes and quality of life.

Drivers:

1. Rising Incidence of Biliary Diseases:

The global burden of hepatobiliary cancers, such as cholangiocarcinoma and pancreatic cancer, is driving the demand for effective biliary drainage solutions. Metal non-covered stents offer superior performance in managing malignant strictures, making them the preferred choice in clinical practice.

2. Shift Toward Minimally Invasive Procedures:

Minimally invasive techniques, particularly endoscopic retrograde cholangiopancreatography (ERCP), are becoming the standard of care for biliary drainage. Metal non-covered stents are compatible with these procedures, promoting their adoption among healthcare providers.

3. Advancements in Stent Design:

Improvements in stent materials, radial force, and anti-migration features have enhanced the functionality and clinical success of metal non-covered biliary stents. These innovations contribute to improved patient outcomes and stent longevity.

Restraints:

1. Risk of Tumor Ingrowth:

Non-covered metal stents are susceptible to tumor ingrowth, which can lead to stent occlusion over time. This limitation may affect their long-term efficacy, particularly in patients with rapidly progressing malignancies.

2. Limited Application in Benign Conditions:

Due to concerns about tissue overgrowth and difficulty in stent removal, non-covered metal stents are rarely used for benign biliary strictures. This restricts their application to malignant cases, limiting overall market potential.

Opportunity:

1. Expansion in Emerging Healthcare Markets:

Countries in Asia-Pacific and Latin America are investing heavily in improving healthcare infrastructure and access to advanced diagnostic and therapeutic procedures. This creates new opportunities for the deployment of metal non-covered biliary stents in these high-potential regions.

2. Integration with Imaging and Navigation Technologies:

The integration of biliary stenting with real-time imaging modalities such as endoscopic ultrasound (EUS) is enhancing procedural accuracy. This synergy is expected to boost adoption rates and broaden the clinical use of metal non-covered stents.

Market by System Type Insights:

Based on system type, the Self-Expanding Metal Stents (SEMS) segment dominated the market in 2023. SEMS are favored due to their ability to conform to the anatomy of the biliary tract, ensuring better drainage and lower rates of migration. They also offer high radial strength and are easier to deploy, making them the first-line choice in malignant biliary obstruction.

Market by End-Use Insights:

In terms of end-use, Hospitals held the largest market share in 2023, accounting for over 65% of global revenue. Hospitals are typically the primary sites for complex endoscopic procedures and are equipped with the infrastructure required for stent deployment. Specialty Clinics and Ambulatory Surgical Centers (ASCs) are expected to witness faster growth due to increased focus on outpatient care and cost-effective treatment settings.

Market by Regional Insights:

North America led the global metal non-covered biliary stent market in 2023, supported by the presence of advanced healthcare systems, high prevalence of hepatobiliary cancers, and widespread adoption of minimally invasive techniques. Meanwhile, the Asia-Pacific region is projected to register the highest growth rate through 2031, driven by improving healthcare access, increasing patient awareness, and rising investments in endoscopic equipment in countries like China, India, and South Korea.

Competitive Scenario:

Key players in the global metal non-covered biliary stent market include:

Boston Scientific Corporation

Cook Medical

Medtronic plc

Olympus Corporation

Taewoong Medical Co., Ltd.

CONMED Corporation

Becton, Dickinson and Company (BD)

ELLA-CS, s.r.o.

Micro-Tech (Nanjing) Co., Ltd.

Merit Medical Systems, Inc.

These companies are focusing on product innovation, regulatory approvals, and regional expansion. For example:

In 2023, Boston Scientific launched an advanced generation of SEMS with enhanced anti-migration properties.

In 2024, Cook Medical expanded its stent portfolio with new sizes tailored for complex biliary anatomies.

Taewoong Medical partnered with Asian hospitals in 2025 to conduct clinical trials on biodegradable stents, aiming to reduce long-term complications.

Scope of Work – Global Metal Non-Covered Biliary Stent Market

Report Metric Details

Market Size (2023) USD 412.3 million

Projected Market Size (2031) USD 758.6 million

CAGR (2023–2031) 7.9%

Market Segments By System Type (SEMS, Others); By End-Use (Hospitals, ASCs, Specialty Clinics); By Region

Growth Drivers Rising incidence of biliary cancer